Qualitative troponin I estimation in the diagnosis of acute coronary syndromes in three rural hospitals.
To examine the utility of point-of-care qualitative troponin I (TnI) testing in patients with possible acute coronary syndromes (ACS). A retrospective chart review of all patients undergoing qualitative TnI testing between September 2001 and February 2002 was conducted at the emergency departments of 3 rural hospitals in Alberta. We looked at the incidence of ACS, the comparison between TnI and creatine kinase (CK) testing and the timing of testing. Of the 235 patients tested, 8 had ST-elevation myocardial infarctions and 11 non ST-elevation infarctions. One patient had unstable angina with minimal myocardial damage. Qualitative TnI testing was positive in all 14 cases of infarction tested more than 6 hours after symptom onset, and CK elevation occurred in 15/17 cases (TnI sensitivity 1.0 [95% confidence interval (CI) 0.78-1.0], CK sensitivity 0.882 [95% CI 0.66-0.97]). There were 3 positive TnI tests and 33 raised CK levels in patients without evidence for ACS (TnI specificity 0.986 [95% CI 0.96-0.99], likelihood ratio [LR] 72.0 [95% CI 23.4-221.5]); CK specificity 0.847 [95% CI 0.79-0.89], LR 5.8 [95% CI 4.0-8.3]). In 44 patients (20.8%) TnI testing was inappropriately not repeated more than 6 hours after symptom onset. Qualitative TnI testing appears highly sensitive and more specific than CK estimation in detecting myocardial infarction. Diagnostic algorithms must emphasize the importance of testing 6 or more hours after symptom onset.